Archive for August 2018

Read/Write DNA Devices

Yesterday I wrote up my notes on Iridia. I think one of the things I find so fascinating about the concept is the potential to create a system that can both read and write DNA. This move to read/write DNA devices seems like a step change from discrete sequencers and synthesizers.

To briefly recap, the Iridia system used nanopore to selectively expose DNA strands to enzymes. The enzymes can’t make their way through the pore, but you can drive the charged DNA strand through the pore under a bias voltage.

The use of a nanopore also clearly lends itself to using this same aperture for sequencing the DNA. This could be through the detection of the blockage of an Ionic current, or embedded electrodes (like some solid state nanopore systems). Either solid-state, or protein nanopores could be used. Apertures might even be constructed in other ways (like Armonica’s tortuous nanopores).

So potentially, you have a DNA synthesis platform, that can also QC the strand at every base incorporation as it passes through from one chamber to another.

One issue with at least some embodiments of the Iridia concept from their patent, is that single nucleotides can make their way through the pore as well was the strand under synthesis. This means they need to remove the terminator from the base already incorporated into the strand only (I think they may have a way of doing this). I guess it can also increase the potential for misincorporation and might complicate the fluidic system.

However it feels like if the correct components can be assembled, you might be able to create a chip system that can read and write DNA and has no external fluidic components.

I thought it might be fun to play around with these ideas a bit…

The diagram below shows what this (Computer Scientist) imagines such a system might look like schematically:

In the above diagram I’ve shown a system with multiple chambers. Each chamber has two apertures shown. One is a nanopore/nanoscale aperture through which only DNA can pass. The other is a valve, which stops all flow into the chamber. The valve can be much bigger than the nanopore, these are all normally closed. Potentially the valve could be part of the pore (for example a voltage gated ion channel [2]) or might not be required at all. But this valve could be large and should be easy to fabricate.

The strand under synthesis sits in the input DNA chamber. You then open the value leading out of this chamber (1) and going to one of the nucleotides, (2) for example. A bias voltage is applied between these chambers to drive the DNA into the correct nucleotide chamber. In this chamber there’s a template independent polymerase. The nucleotides in this chamber are terminated, such that only a single nucleotide is incorporated into the strand.

The bias voltage is then reversed, and the strand flows back into the “input” chamber. A number of single nucleotides come along for the ride. However in the input chamber the strand is captured. This could be by hybridising to an immobilized complementary strand, though there might be other methods. With the strand captured you reverse the bias voltage again and the single nucleotides flow back into their original chamber. You can then close the valves to keep them contained. The strand is released by heating the strand, melting it.

Next you need to cleave the terminator. This will depend on the type of terminator used. One possibility might be to use photo-cleavable terminators such as those developed by LaserGen [1]. If this is the case, then you would just need to turn on a light source to remove the terminator. Another chamber could be used however, particularly if there is some other process (perhaps there’s an enzymatic process?) that is used to remove the terminator.

The process would then continue as above cyclically. Depending on the quality of the pores/apertures, you can also measure the ionic current as the strand passes through the pore. This may be sufficient to determine the sequence during synthesis.

In any case, once synthesis is complete you can open another valve (7) and set bias voltages between the chambers (input and holding for QC chambers) such that the DNA will flow through an exit pore. This pore could be specifically designed for sequencing and might have additional embedded electrodes to enable this.

You could also QC the strand (did synthesis complete correctly?) and sort the strand accordingly.

Of course, the same system could also be used as a read system only, just insert complete strands at the start of the process.

Potentially all the nucleotides and reagents could come preloaded, giving a simple, almost solidstate system. While initially it might be desirable to fabricate only certain parts of the system using nanofabrication, ultimately it might be possible to integrate all components onto a single chip.

Notes

[1] https://webcache.googleusercontent.com/search?q=cache:hkUhGFAhmmgJ:https://www.genomeweb.com/sequencing/lasergen-says-its-new-reversible-terminators-could-improve-several-sequencing-pl+&cd=15&hl=en&ct=clnk&gl=jp

[2] https://en.wikipedia.org/wiki/Voltage-gated_ion_channel

Iridia (was Dodo Omnidata)

While putting together my list of synthesis companies, one particular stood out. Not least because of its original name, Dodo Omnidata (which is awesome) [3]. But also because the technology is significantly different from anything else on the list being inherently single molecule. The company also seems to be relatively unknown.

For these reasons, I’m writing up some quick notes.

Business

Dodo Omnidata was founded in 2016. They seem to have raised ~400K in seed funding in 2017. An SEC filing shows they raised ~2MUSD this June. Jay Flatley (ex-Illumina CEO) is on the board. The initial 400K came from Tech Coast Angels according to Crunchbase. It’s not clear where the most recent raise came from, but with Jay on the board, it seems possible there’s a connection to Illumina Ventures.

Technology

There’s not much on the website, but there is a 134 page patent. I’ve barely skimmed it but what’s clear is that they suggest using nanopores for DNA synthesis:

From by quick skim, it appears that what they suggest is driving a strand of DNA through a nanopore with a bias voltage. In this way they can move it between two chambers. In itself I don’t believe that is particularly novel. What’s neat is that because enzymes are too big to go through the nanopore they can selectively expose the strand to different enzymes under electrical control.

They use this for synthesis by having one chamber containing a template independent polymerase (a polymerase that just adds any base you give it) and a base with a terminator on it (so only a single base is added). My guess is that you’d flow bases in cyclically. If you want to incorporate a base into the strand, you flip the voltage and pull the strand through the nanopore. Leave it for a while to incorporate the base, then pull it back out.

Back on the other side of the pore, another enzyme comes in and removes the block on the strand. As single nucleotides can also pass through the pore, it’s desirable to have an enzyme that only removes terminators on bases incorporated into the strand.

In practice I would imagine the whole system can be arrayed. And you’d be flowing bases onto one side of an array. How competitive this system is with other enzymatic approaches is something I don’t know. But it seems pretty neat!

Notes

[1] 2018 SEC Filing: https://www.sec.gov/Archives/edgar/data/1708118/000170811818000002/0001708118-18-000002-index.htm

[2] http://www.freepatentsonline.com/WO2017151680A2.pdf

[3] In case you’re curious about the binary encircling the old Dodo Omnidata logo it converts to Data Vida in ASCII. Vida is Spanish for life, and I assume is a reference to the tagline “Data for Life” also on their banner.

DNA Synthesis Companies (August 2018)

Below is a list of DNA Synthesis Companies, to complement my list of sequencing companies. It’s not quite as complete, I’ve missed out some seemingly established players who didn’t seem particularly entertaining and/or only run service businesses.

There’s a great list here which includes some defunct companies, and other approaches.

Name Further Info Blog post Status Method Location
Ansa Biotechnologies Company Website Pre-seed? Enzymatic Bay Area
CustomArray Inc. Company Website Acquired Electrochemical Seattle
DNA Script Company Website Series A Enzymatic Paris
Evonetix Company Website Series A Thermal Cambridge, UK
Agilent Company Website IPO Printing Int.
Iridia (was dodo omnidata) Company Website Blog Series A Nanopore Carlsbad, California
Kilobaser Company Website Seed/Series A? Fluidic Austria
LabGenius Company Website Seed/Series A? Assembly? London
Molecular Assemblies Company Website Series A Enzymatic San Diego
Nuclera Nucleics Company Website Seed Enzymatic Cambridge, UK
SGI DNA Company Website Established Fluidic La Jolla
Synthomics Company Website Seed Fluidic Bay Area
Twist Biosciences Company Website Series E Printing Bay Area

Northshore Biosciences

Northshore Biosciences popped up on my radar again recently. There’s not a lot of information on the web, so I decided to skip forward in my list of DNA sequencing companies and write up a few notes on them.

Business

Northshore Biosciences was founded in 2009 as Lux Bio Group, Inc. [8] by Jonathan DeHart and Gordon Holt. A 2013 Genomeweb article states that an undisclosed series A was raised from Oregon Angel Fund and the ISB (Institute for Systems Biology?) [2].

A 2014 report by the Keiretsu Forum (a group of angel investors) states that they invested 21.2M USD in 35 companies during 2013 (including Northshore Bio). The average investment from Keiretsu was ~600K. SEC filings seem to indicate they’ve raise about 3M USD. Overall, it appears they’ve raise a few million and are at series A stage.

Technology

The Northshore Bio site doesn’t describe the technology in any depth, but it does show a nice video.

The fundamental Northshore approach is to create what they call “tuneable nanopores”. This is a fabrication approach where they create an aperture and then try and fill it in until they have a much smaller hole through which they can detect the translocation of bases. The genomeweb article suggests they are targeting 20nm long and 10nm wide nanopores.

It appears they are also proposing what they call “sequencing-by-degradation”. This is similar to the original Oxford Nanopore approach. Here an exonuclease, positioned near the aperture chews individual bases off a strand. These individual bases then go through the pore and are detected.

The pore size suggested (20nm by 10nm) is large when compared to typical protein nanopores, which typically have constrictions of 1 to 3nm:

Example Protein Nanopore dimensions from [5].

Solid state nanopores too, have achieved dimensions in the single digit nanometer range:

Example solid state nanopores from [6].

So it’s likely that the large dimensions of the pore somewhat motivate the decision to use an exonuclease, single nucleotide detection approach. One potential issue here is the dwell time of the bases in the nanopore. In many single base detection experiments the dwell time of bases is non-gaussian. There are many nucleotides that go through the pore so quickly that you can’t detect them:

Base dwell times from [7].

In addition to the basic method shown on their site, Northshore Bio appear to have a number of patents (still assigned to Lux Bio Group Inc.) [1].

The patents discuss a number of different approaches. These include:

* Creating a small aperture, in which a bilayer just big enough for a single nanopore is formed (this could help with issues with multiple insertion of pores in other systems).
* Nanowells with sidewall electrodes.
* Nano-membranes which can change shape.
* Depositing membranes under electro-chemical control.

Most of the patents appeared to be continuations, and all authored by Gordon Holt. I looked through the patents for data (SEM images, or experimental data) and couldn’t find anything. It’s possible there’s more stuff in the pipeline.

The Northshore approach seems interesting, but not without significant challenges. I’d guess they will need significant funding to move forward (anything that involves nano fabrication does!). Will be watching with interest!

Notes

[1] Patent, Lux Bio Group: http://www.freepatentsonline.com/y2017/0298432.html
[2] Genomeweb article: https://www.genomeweb.com/sequencing/northshore-bio-develops-solid-state-tunable-nanopore-chips-sequencing-degradatio
“In late 2011, NorthShore Bio raised an undisclosed amount of funding in a Series A round with the Oregon Angel Fund and the ISB.”
“For sequencing applications, the company is targeting pore dimensions of less than 20 nanometers in length and 10 nanometers in diameter, similar to the nanopores explored for sequencing by others.”
“For sequencing, NSB is pursuing a sequencing-by-degradation approach, which is similar in principle to the exonuclease sequencing strategy Oxford Nanopore was exploring before it abandoned it in favor of DNA strand sequencing.”

[4] https://www.k4northwest.com/down/eJzLKCkpsNLXL87MyS4uSSwq0Ss21kvMTazKz0ssL9ZLzs%40VNzU2TjMyNDcB0pYG5gYphhYmZkaJpsZ6BSlpAJ08E30%3D/Keiretsu%20%20Forum%20Northwest%202013%20Funding%20Press%20Release.pdf

[5] https://doi.org/10.1016/j.tibtech.2011.07.006

[6] https://www.researchgate.net/publication/303696326_Solid-State_Nanopore-Based_DNA_Sequencing_Technology

[7] http://www.nature.com/articles/nnano.2009.12

[8] There’s still an old website online for Lux Bio Group: http://luxbiogroup.com/index.html

[9] https://www.whoisraisingmoney.com/lux-bio-group-inc